innospec
Innovation is an idea in action! Prof. Hans-Jürgen Quadbeck-Seeger

innospec is a young company representing over 10 years’ experience in several industries markets and have managed various international projects. We are living an open culture in communication with clients & partners to create a new comfort zone in success area. innospec has expert insights in Healthcare leading several integration projects of startups successful into leading industry companies based on market research, consulting and prototyping.

innospec strength lies in its understanding of the two scientific & business worlds and ability to deal with these challenges. We are able to speak and translate the language of scientists and business managers to create a new platform of communication and interaction for new innovations.

Portfolio & performance spectrum

Transfermanagement Portfolio

Transfermanagement Projects

  1. A precision X-ray procedure is designed to detect cancer earlier and to improve the development and control of drugs. This has now been done by the research team headed by Prof. Dr. med. Florian Grüner from the Department of Physics of the University of Hamburg reports in the journal "Scientific Reports". A test of the so-called X-ray fluorescence for this application at the DESY research light source PETRA III has been promising. The method therefore offers the prospect not only to carry out such X-ray examinations more accurately, but also more gently than with previous methods. The idea behind the method is simple: tiny gold nanoparticles are peppered with antibodies. These nanoparticles would be injected into a patient. The particles travel through the body, with the antibodies docking on any existing tumors. Scanning the patient with a hair-thin X-ray beam, the gold particles fluoresce and emit characteristic X-ray signals recorded by a special detector. As a result, it would be possible to detect the smallest tumors that cannot be found with current methods or that revolutionize the pharmacokinetics of drug research. innospec accompanies this team and has already engaged international pharmaceutical companies in research assignments.

  2. innospec maintains a strong network with universities such as the University of Hamburg (UHH) and Magdeburg (OvGU), in particular in the fields of Accelerator Physics Group, Faculty of Electrical Engineering, Information Technology and Institute of Medical Technology. With the knowledge of new IPs, publications or projects from universities, innospec connects science with potential industry partners for contract research or product integration.

Market Research Portfolio

Market Research Projects

  1. innospec created the market research “Offering the next generation of brilliant x-ray sources to science and industry” for the EU-Project CHAMPP by providing interview partners in leading positions from international medical imaging companies and a deep dive of Free-Electron-Laser (FEL) Technology.

Consulting Portfolio

Consulting Projects

  1. Easy3D GmbH holds patents for a 3D screen-solution used without glasses. innospec advised leading management in creating market adopted business plans and optimizing internal communication between R&D and Operational Management.

Prototyping Portfolio

Prototyping Projects

  1. HOTRAY Ldt providing the first real Radiation dose monitoring APP for smartphone in App-Stores called “RadioactivityCounter”. It was successful tested from several institutes and industry laboratories as an alternative to industry Geiger-Müller-counter or dosimeter (analog/digital). innospec is supporting development and creating business plans for market access of this digital prototype.
  2. MEDI-OPT GmbH holds patent for a digital solution of a dosimeter, which will pass technical certification to fulfill legal occupational dose by PTB to exchange analog film dosimeter. innospec supports the development and creating business plans for market access of this digital prototype.

Kontakt

* Pflichtfeld